133 related articles for article (PubMed ID: 12487777)
1. Influence of heparin coating of coronary stents and ex vivo efficacy of different doses of acetylsalicylic acid and ticlopidine in a pulsed floating model of recirculating human plasma.
Brockmann MA; Gutensohn K; Bau J; Kuehnl P; Meinertz T; Nienaber C; Beythien C
Platelets; 2002 Dec; 13(8):443-9. PubMed ID: 12487777
[TBL] [Abstract][Full Text] [Related]
2. Reduction of subacute stent thrombosis (SAT) using heparin-coated stents in a large-scale, real world registry.
Gupta V; Aravamuthan BR; Baskerville S; Smith SK; Gupta V; Lauer MA; Fischell TA
J Invasive Cardiol; 2004 Jun; 16(6):304-10. PubMed ID: 15155999
[TBL] [Abstract][Full Text] [Related]
3. The effect of antiplatelet drugs clopidogrel and aspirin is less immediately after stent implantation.
Siller-Matula JM; Haberl K; Prillinger K; Panzer S; Lang I; Jilma B
Thromb Res; 2009 Apr; 123(6):874-80. PubMed ID: 19135705
[TBL] [Abstract][Full Text] [Related]
4. Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation.
Monnink SH; van Boven AJ; Peels HO; Tigchelaar I; de Kam PJ; Crijns HJ; van Oeveren W
J Investig Med; 1999 Jul; 47(6):304-10. PubMed ID: 10431485
[TBL] [Abstract][Full Text] [Related]
5. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS
J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660
[TBL] [Abstract][Full Text] [Related]
6. Effects on blood compatibility in vitro by combining a direct P2Y12 receptor inhibitor and heparin coating of stents.
Christensen K; Larsson R; Emanuelsson H; Elgue G; Larsson A
Platelets; 2006 Aug; 17(5):318-27. PubMed ID: 16928604
[TBL] [Abstract][Full Text] [Related]
7. Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis: a case-control study.
Ajzenberg N; Aubry P; Huisse MG; Cachier A; El Amara W; Feldman LJ; Himbert D; Baruch D; Guillin MC; Steg PG
J Am Coll Cardiol; 2005 Jun; 45(11):1753-6. PubMed ID: 15936600
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and potency of antiplatelet activity of ticlopidine is increased by aspirin.
Splawinska B; Kuzniar J; Malinga K; Mazurek AP; Splawinski J
Int J Clin Pharmacol Ther; 1996 Aug; 34(8):352-6. PubMed ID: 8864799
[TBL] [Abstract][Full Text] [Related]
9. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
Am J Cardiol; 2006 Jan; 97(1):38-43. PubMed ID: 16377281
[TBL] [Abstract][Full Text] [Related]
10. Stent thrombosis is associated with an impaired response to antiplatelet therapy.
Wenaweser P; Dörffler-Melly J; Imboden K; Windecker S; Togni M; Meier B; Haeberli A; Hess OM
J Am Coll Cardiol; 2005 Jun; 45(11):1748-52. PubMed ID: 15936599
[TBL] [Abstract][Full Text] [Related]
11. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
Bavry AA; Kumbhani DJ; Helton TJ; Bhatt DL
J Am Coll Cardiol; 2005 Mar; 45(6):941-6. PubMed ID: 15766833
[TBL] [Abstract][Full Text] [Related]
12. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
[TBL] [Abstract][Full Text] [Related]
14. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement.
Hochholzer W; Trenk D; Bestehorn HP; Fischer B; Valina CM; Ferenc M; Gick M; Caputo A; Büttner HJ; Neumann FJ
J Am Coll Cardiol; 2006 Nov; 48(9):1742-50. PubMed ID: 17084243
[TBL] [Abstract][Full Text] [Related]
15. Platelet activation after stenting with heparin-coated versus noncoated stents.
Gurbel PA; Bliden KP
Am Heart J; 2003 Oct; 146(4):E10. PubMed ID: 14564333
[TBL] [Abstract][Full Text] [Related]
16. [Optimal platelet inhibition after coronary stent implantation. Current status].
Silber S; Hoffmeister HM; Bode C
Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
[TBL] [Abstract][Full Text] [Related]
17. What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?
Steinhubl S; Berger P
Am Heart J; 2003 Jun; 145(6):971-8. PubMed ID: 12796751
[TBL] [Abstract][Full Text] [Related]
18. Tantalum stents induce expression of GMP140 and GP53 on platelets after contact in an in vitro model.
Gutensohn K; Beythien C; Bau J; Meinertz T; Kühnl P
Beitr Infusionsther Transfusionsmed; 1996; 33():61-5. PubMed ID: 8865937
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
Lepäntalo A; Virtanen KS; Reséndiz JC; Mikkelsson J; Viiri LE; Karhunen PJ; Lassila R
Thromb Res; 2009 Jun; 124(2):193-8. PubMed ID: 19232433
[TBL] [Abstract][Full Text] [Related]
20. Heparin-coating of coronary stents.
van der Giessen WJ; van Beusekom HM; Eijgelshoven MH; Morèl MA; Serruys PW
Semin Interv Cardiol; 1998; 3(3-4):173-6. PubMed ID: 10406689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
